APA (7th ed.) Citation

Dietz, J., Vermehren, J., Matschenz, K., Buggisch, P., Klinker, H., Schulze zur Wiesch, J., . . . Sarrazin, C. (2020). Treatment outcomes in hepatitis C virus genotype 1a infected patients with and without baseline NS5A resistance‐associated substitutions. Liver International, 40(11), 2660. https://doi.org/10.1111/liv.14591

Chicago Style (17th ed.) Citation

Dietz, Julia, et al. "Treatment Outcomes in Hepatitis C Virus Genotype 1a Infected Patients with and Without Baseline NS5A Resistance‐associated Substitutions." Liver International 40, no. 11 (2020): 2660. https://doi.org/10.1111/liv.14591.

MLA (9th ed.) Citation

Dietz, Julia, et al. "Treatment Outcomes in Hepatitis C Virus Genotype 1a Infected Patients with and Without Baseline NS5A Resistance‐associated Substitutions." Liver International, vol. 40, no. 11, 2020, p. 2660, https://doi.org/10.1111/liv.14591.